EPISODE · Mar 23, 2026 · 9 MIN
今天3分钟我们来聊聊206例干细胞治疗脑梗随机双盲临床公布
from 源于细胞BioInsid的个人播客
日本TREASURE研究评估干细胞治疗急性缺血性脑卒中的安全性和疗效。206名中重度患者参与，干细胞组32%恢复至mRS 0-2，安慰剂组28%，虽无显著差异，但干细胞组16%达严格恢复标准，安慰剂组10%，且安全性良好，为脑梗治疗带来新方向。前往小宇宙评论区与主播互动
Embed this episode
Ready to play
今天3分钟我们来聊聊206例干细胞治疗脑梗随机双盲临床公布
0:00
9:22
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 源于细胞BioInsid的个人播客?
This episode is 9 minutes long.
When was this 源于细胞BioInsid的个人播客 episode published?
This episode was published on March 23, 2026.
Can I download this 源于细胞BioInsid的个人播客 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!